JHAH Announces State-of-the-Art Oncology Center of Excellence at Arab Health 2025, Setting a Global Benchmark for Cancer Care in the GCC

(MENAFN- APCO Worldwide) Dubai, UAE– 31 January 2025: Johns Hopkins Aramco Healthcare (JHAH) has revealed the launch of its state-of-the-art Oncology Center of Excellence at Arab health 2025, the largest and most prestigious healthcare exhibition in the MENA region. Based in Saudi Arabia and accessible to patients across the GCC, the center integrates Johns Hopkins Medicine’s globally renowned oncology expertise with the Kingdom’s advanced healthcare infrastructure, delivering tailored solutions to meet the unique needs of the region.

With cancer cases in the GCC projected to increase by over 140% between 2020 and 2040, the center addresses the urgent need for advanced, specialized oncology care. Reflecting the Arab Health 2025 theme, ‘Where the world of healthcare meets’, the launch highlights JHAH’s dedication to overcoming regional healthcare challenges, aligning with international standards, and solidifying the GCC’s leadership in delivering world-class oncology services on the global stage.

Specializing in breast, colorectal, and prostate cancers—three of the most prevalent cancers in the GCC—the Oncology Center of Excellence provides a comprehensive approach to cancer care. Its offerings include early detection, precision diagnostics, advanced treatments, and survivorship programs, establishing a holistic and patient-centered model of care. With evidence-based protocols, cutting-edge technologies, and a multidisciplinary team of specialists, the facility serves as a pillar of global excellence for oncology care originating from the GCC.

Dr. Michael Walsh, CEO of JHAH, said, “The launch of the Oncology Center of Excellence marks a pivotal moment in our partnership with Johns Hopkins Medicine, demonstrating our shared commitment to advancing healthcare in Saudi Arabia and the wider GCC. By integrating Johns Hopkins Medicine’s globally recognized expertise with Saudi Arabia’s cutting-edge healthcare infrastructure, we are responding to the region's oncology challenges while setting a new global standard for cancer care.”
“This center is a testament to the power of international collaboration in transforming healthcare delivery. By implementing evidence-based protocols and utilizing cutting-edge technologies developed by Johns Hopkins Medicine in the U.S., we are ensuring that patients across the GCC have access to world-class cancer care.

This milestone reinforces our mission to provide innovative, patient-focused solutions and strengthens the GCC’s position as a hub for global medical excellence,” he added.
The Oncology Center of Excellence is built on Aramco’s decade-long partnership with Johns Hopkins Medicine, combining internationally recognized expertise with regionally tailored solutions. By addressing the specific healthcare challenges of the GCC, the center serves as a testament to how the region is driving advancements in oncology care while contributing to global healthcare innovation.


Dr. Brian Matlaga, Executive Medical Director of Clinical Affairs for Johns Hopkins Medicine International, said, “Our expanded partnership with JHAH reaffirms our shared vision of transforming healthcare in Saudi Arabia and beyond by contributing to world-class expertise, knowledge and cutting-edge innovation in the region. The launch of JHAH’s Oncology Center of Excellence builds on the legacy of Johns Hopkins Medicine’s global excellence in patient care, education and research, providing comprehensive, integrated, multidisciplinary care that delivers the best possible patient outcomes and experience for patients and families. Experts in every dimension of cancer care—each deeply specializing in one type of cancer—will work together to diagnose each patient, develop personalized treatment and survivorship plans of care, and incorporate the patient’s and family’s preferences. Our guiding principle is to provide patients the same high-quality oncology care journey, whether they are at Johns Hopkins Medicine in the United States or at JHAH in Dhahran.”



-ENDS-

MENAFN01022025002825016959ID1109155835